Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Gap junction protein, gamma 2 (GJC2) gene sequencing test Neurogenetics Department Cyprus Institute of Neurology and Genetics Cyprus | 1 | 1 |
|
Invitae Cerebral Palsy Spectrum Disorders Panel Invitae United States | 638 | 419 |
|
Complex Hereditary Spastic Paraplegia Panel PreventionGenetics, part of Exact Sciences United States | 72 | 87 |
|
Hereditary Spastic Paraplegia Comprehensive Panel PreventionGenetics, part of Exact Sciences United States | 87 | 106 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 480 | 254 |
|
Invitae Hereditary Spastic Paraplegia Comprehensive Panel Invitae United States | 98 | 62 |
|
GJC2 Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States | 3 | 1 |
|
GJC2 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 3 | 1 |
|
Baylor Genetics United States | 3 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 3 | 1 |
|
Spastic paraplegia type 44 (SPG44, sequence analysis of GJC2 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Leukodystrophy and leukoencephalopathy panel. NGS panel of 74 genes. Genologica Medica Spain | 96 | 74 |
|
Lymphatic malformations and related disorders panel. NGS panel of 11 genes. Genologica Medica Spain | 31 | 11 |
|
Complete epilepsy panel. NGS panel of 283 genes. Genologica Medica Spain | 409 | 283 |
|
Genologica Medica Spain | 100 | 60 |
|
Genetiks Genetic Diagnosis Center Genetic Diseases Evaluation Center Turkey | 1 | 1 |
|
Spastic paraplegia: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 55 | 54 |
|
Fulgent Genetics United States | 505 | 132 |
|
Hypomyelinating Leukodystrophy NGS Panel Fulgent Genetics United States | 225 | 62 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.